Targeting the Source: Dissecting the Mechanisms of Emerging B-Cell Therapies in IgA Nephropathy

Discover how novel APRIL and dual BAFF/APRIL inhibitors directly interrupt IgA nephropathy pathogenesis.

Credit available for this activity expires: 9/29/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/targeting-source-dissecting-mechanisms-emerging-b-cell-2026a1000zi7?ecd=bdc_podcast_libsyn_mscpedu